MetLife Investment Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,608
| Closed | -$110K | – | 2859 |
|
|
2024
Q2 | $110K | Buy |
5,608
+586
| +12% | +$11.5K | ﹤0.01% | 2560 |
|
|
2024
Q1 | $129K | Buy |
5,022
+2,296
| +84% | +$58.8K | ﹤0.01% | 2420 |
|
|
2023
Q4 | $75.2K | Hold |
2,726
| – | – | ﹤0.01% | 2717 |
|
|
2023
Q3 | $166K | Hold |
2,726
| – | – | ﹤0.01% | 2312 |
|
|
2023
Q2 | $179K | Hold |
2,726
| – | – | ﹤0.01% | 2344 |
|
|
2023
Q1 | $173K | Buy |
2,726
+545
| +25% | +$34.7K | ﹤0.01% | 2301 |
|
|
2022
Q4 | $302K | Buy |
2,181
+280
| +15% | +$38.8K | ﹤0.01% | 1990 |
|
|
2022
Q3 | $241K | Hold |
1,901
| – | – | ﹤0.01% | 2163 |
|
|
2022
Q2 | $157K | Buy |
1,901
+1,147
| +152% | +$95K | ﹤0.01% | 2466 |
|
|
2022
Q1 | $73.2K | Sell |
754
-471
| -38% | -$45.7K | ﹤0.01% | 2651 |
|
|
2021
Q4 | $245K | Sell |
1,225
-666
| -35% | -$133K | ﹤0.01% | 1934 |
|
|
2021
Q3 | $468K | Hold |
1,891
| – | – | ﹤0.01% | 1556 |
|
|
2021
Q2 | $783K | Buy |
+1,891
| New | +$783K | 0.01% | 1306 |
|
|
2019
Q2 | – | Sell |
-6
| Closed | -$11.6K | – | 2449 |
|
|
2019
Q1 | $11.6K | Hold |
6
| – | – | ﹤0.01% | 2382 |
|
|
2018
Q4 | $7.34K | Hold |
6
| – | – | ﹤0.01% | 2414 |
|
|
2018
Q3 | $11K | Buy |
+6
| New | +$11K | ﹤0.01% | 2429 |
|
|
2018
Q1 | – | Sell |
-1,706
| Closed | -$3.94M | – | 2200 |
|
|
2017
Q4 | $3.94M | Buy |
+1,706
| New | +$3.94M | 0.04% | 474 |
|